These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 9580623

  • 1. Stabilization of vasoactive intestinal peptide by lipids.
    Gololobov G, Noda Y, Sherman S, Rubinstein I, Baranowska-Kortylewicz J, Paul S.
    J Pharmacol Exp Ther; 1998 May; 285(2):753-8. PubMed ID: 9580623
    [Abstract] [Full Text] [Related]

  • 2. Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation.
    Stark B, Andreae F, Mosgoeller W, Edetsberger M, Gaubitzer E, Koehler G, Prassl R.
    Eur J Pharm Biopharm; 2008 Sep; 70(1):153-64. PubMed ID: 18555674
    [Abstract] [Full Text] [Related]

  • 3. Liposomal vasoactive intestinal peptide.
    Sethi V, Onyüksel H, Rubinstein I.
    Methods Enzymol; 2005 Sep; 391():377-95. PubMed ID: 15721392
    [Abstract] [Full Text] [Related]

  • 4. Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery.
    Stark B, Debbage P, Andreae F, Mosgoeller W, Prassl R.
    Biochim Biophys Acta; 2007 Mar; 1768(3):705-14. PubMed ID: 17204237
    [Abstract] [Full Text] [Related]

  • 5. Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties.
    Haghjoo K, Cash PW, Farid RS, Komisaruk BR, Jordan F, Pochapsky SS.
    Pept Res; 1996 Mar; 9(6):327-31. PubMed ID: 9048428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I, Vertongen P, Langer I, Perret J, Robberecht P, Waelbroeck M.
    Biochem J; 2003 Mar 15; 370(Pt 3):1003-9. PubMed ID: 12475394
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of a hydrophilic affinity matrix for the purification of the vasoactive intestinal peptide receptor.
    Fournier A, Couvineau A, Laburthe M.
    Anal Biochem; 1993 Jun 15; 211(2):305-10. PubMed ID: 8391225
    [Abstract] [Full Text] [Related]

  • 9. Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability.
    Dangoor D, Biondi B, Gobbo M, Vachutinski Y, Fridkin M, Gozes I, Rocchi R.
    J Pept Sci; 2008 Mar 15; 14(3):321-8. PubMed ID: 17924396
    [Abstract] [Full Text] [Related]

  • 10. Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
    Igarashi H, Ito T, Mantey SA, Pradhan TK, Hou W, Coy DH, Jensen RT.
    J Pharmacol Exp Ther; 2005 Oct 15; 315(1):370-81. PubMed ID: 15994369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
    Paul S, Volle DJ, Mei S.
    J Immunol; 1990 Aug 15; 145(4):1196-9. PubMed ID: 2380555
    [Abstract] [Full Text] [Related]

  • 14. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.
    Onyüksel H, Ashok B, Dagar S, Sethi V, Rubinstein I.
    Peptides; 2003 Feb 15; 24(2):281-6. PubMed ID: 12668213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
    Ashok B, Rubinstein I, Tsueshita T, Onyüksel H.
    Peptides; 2004 Aug 15; 25(8):1253-8. PubMed ID: 15350692
    [Abstract] [Full Text] [Related]

  • 19. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
    Johnson JE, Rao NM, Hui SW, Cornell RB.
    Biochemistry; 1998 Jun 30; 37(26):9509-19. PubMed ID: 9649334
    [Abstract] [Full Text] [Related]

  • 20. Novel extended and branched N-terminal analogs of VIP.
    Dangoor D, Rubinraut S, Fridkin M, Gozes I.
    Regul Pept; 2006 Nov 15; 137(1-2):42-9. PubMed ID: 16962672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.